Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Neuroscience

• Publication date

  2009-09-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.neuroscience.2009.05.040PMID 19467297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism.

  2008cited by this paper
• Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism.

  2008cited by this paper
• A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model.

  2008cited by this paper
• Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.

  2008cited by this paper
• Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats.

  2007cited by this paper
• Evaluation of N-Desmethylclozapine as a Potential Antipsychotic—Preclinical Studies

  2007cited by this paper
• The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors

  2007cited by this paper
• L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.

  2007cited by this paper
• The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat

  2006cited by this paper
• Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243.

  2005cited by this paper
• Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat.

  2005cited by this paper
• Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson’s disease

  2005cited by this paper
• Quetiapine (Seroquel) shows a pattern of behavioral effects similar to the atypical antipsychotics clozapine and olanzapine: studies with tremulous jaw movements in rats

  2005cited by this paper
• Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.

  2005cited by this paper
• New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists.

  2005cited by this paper
• Potentiation of sympathetic neuromuscular transmission mediated by muscarinic receptors in guinea pig isolated vas deferens

  2005cited by this paper
• Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat

  2005cited by this paper
• Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine

  2005cited by this paper
• Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice.

  2004cited by this paper
• Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity

  2004cited by this paper
• Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.

  2004cited by this paper
• Pimozide in the treatment of newly admitted schizophrenic patients

  2004cited by this paper
• The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.

  2004cited by this paper
• Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats

  2004cited by this paper
• Modulation of muscarinic facilitation of epileptiform discharges in immature rat neocortex.

  2004cited by this paper
• Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders.

  2004cited by this paper
• Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat

  2004cited by this paper
• Substantia nigra pars reticulata GABA is involved in the regulation of operant lever pressing: pharmacological and microdialysis studies.

  2003cited by this paper
• Brain implantations of engineered GABA-releasing cells suppress tremor in an animal model of Parkinsonism.

  2003cited by this paper
• Motor effects of GABAA antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats

  2003cited by this paper
• Receptor heteromerization in adenosine A2A receptor signaling

  2003cited by this paper
• Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic‐intermittent L‐dopa and A2A receptor blockade plus L‐Dopa in dopamine‐denervated rats

  2002cited by this paper
• Animal models of neurological deficits: how relevant is the rat?

  2002cited by this paper
• Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum

  2002cited by this paper
• Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol.

  2002cited by this paper
• Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back

  2002cited by this paper
• Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum

  2001cited by this paper
• Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism.

  2001cited by this paper
• Biotinylated m4-toxin demonstrates more M4 muscarinic receptor protein on direct than indirect striatal projection neurons.

  2001cited by this paper
• Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates.

  2001cited by this paper
• Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A2A receptors in the caudate‐putamen of rats

  2001cited by this paper
• Comparative effects of scopolamine and quinpirole on the striatal fos expression induced by stimulation of D(1) dopamine receptors in the rat.

  2001cited by this paper
• Interactions between dopamine D1 receptors and γ-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies

  2001cited by this paper
• The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice

  2001cited by this paper
• Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease.

  2001cited by this paper
• The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice.

  2001cited by this paper
• Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease

  2001cited by this paper
• SCH 58261, an A2A adenosine receptor antagonist, counteracts parkinsonian‐like muscle rigidity in rats

  2001cited by this paper
• Rescue of Locomotor Impairment in Dopamine D2 Receptor-Deficient Mice by an Adenosine A2A Receptor Antagonist

  2000cited by this paper
• Carbon-11-labeled KF21213: a highly selective ligand for mapping CNS adenosine A(2A) receptors with positron emission tomography.

  2000cited by this paper
• Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.

  2000cited by this paper
• Region‐specific induction of ΔFosB by repeated administration of typical versus atypical antipsychotic drugs

  1999cited by this paper
• Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.

  1999cited by this paper
• Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats

  1999cited by this paper
• PD 102807, a novel muscarinic M4 receptor antagonist, discriminates between striatal and cortical muscarinic receptors coupled to cyclic AMP.

  1999cited by this paper
• M3 muscarinic receptor activation of a delayed rectifier potassium current in canine atrial myocytes.

  1999cited by this paper
• DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity.

  1999cited by this paper
• Behavioral assessment of atypical antipsychotics in rats: studies of the effects of olanzapine (Zyprexa)

  1999cited by this paper
• Distribution, biochemistry and function of striatal adenosine A2A receptors.

  1999cited by this paper
• Spontaneously hypertensive rats cholinergic hyper‐responsiveness: central and peripheral pharmacological mechanisms

  1999cited by this paper
• Involvement of Adenosine A2A Receptors in the Induction of C-Fos Expression by Clozapine and Haloperidol

  1999cited by this paper
• Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation

  1999cited by this paper
• Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat

  1998cited by this paper
• Subtypes of muscarinic receptors regulating gallbladder cholinergic contractions.

  1998cited by this paper
• Involvement of basal ganglia transmitter systems in movement initiation.

  1998cited by this paper
• Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system

  1998cited by this paper
• Tremulous jaw movements in rats: a model of parkinsonian tremor.

  1998cited by this paper
• Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence

  1998cited by this paper
• Behavioral and electromyographic characterization of the local frequency of tacrine-induced tremulous jaw movements.

  1998cited by this paper
• Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats.

  1997cited by this paper
• Adenosine-dopamine interactions in the ventral striatum Implications for the treatment of schizophrenia

  1997cited by this paper
• Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs.

  1997cited by this paper
• Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects.

  1997cited by this paper
• Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen.

  1997cited by this paper
• Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function

  1997cited by this paper
• Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions.

  1997cited by this paper
• Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.

  1997cited by this paper
• Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas.

  1997cited by this paper
• Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia.

  1997cited by this paper
• Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum

  1996cited by this paper
• Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible model of parkinsonian tremor.

  1996cited by this paper
• Scopolamine augments C-fos and zif/268 messenger rna expression induced by the full D1 dopamine receptor agonist SKF-82958 in the intact rat striatum

  1996cited by this paper
• Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: potent block by the selective m4 ligand muscarinic toxin 3 (MT3)

  1996cited by this paper
• D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.

  1995cited by this paper
• Antiparkinsonian Drugs in the Treatment of Neuroleptic-Induced Extrapyramidal Symptoms

  1994cited by this paper
• KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.

  1994cited by this paper
• Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype- specific antibodies

  1994cited by this paper
• Vacuous jaw movements in rats induced by acute reserpine administration: interactions with different doses of apomorphine.

  1993cited by this paper
• Effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats.

  1993cited by this paper
• Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.

  1992cited by this paper
• Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum.

  1992cited by this paper
• D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons.

  1992cited by this paper
• Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action.

  1992cited by this paper
• Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms

  1991cited by this paper
• Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study

  1991cited by this paper
• Induction of c‐fos mRNA Expression in Rat Striatum by Neuroleptic Drugs

  1990cited by this paper
• Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.

  1990cited by this paper
• D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons.

  1990cited by this paper
• Primate models of movement disorders of basal ganglia origin.

  1990cited by this paper
• Parkinson's Disease and Movement Disorders

  1988cited by this paper

• Hypothetical Mechanism of Resting Tremor in Parkinson’s Disease

  2022cites this paper
• The non-selective adenosine antagonist theophylline reverses the effects of dopamine antagonism on tremor, motor activity and effort-based decision-making.

  2020cites this paper
• Istradefylline to Treat Patients with Parkinson’s Disease Experiencing “Off” Episodes: A Comprehensive Review

  2020cites this paper
• c-Fos and FosB/ΔFosB colocalizations in selected forebrain structures after olanzapine, amisulpride, aripiprazole, and quetiapine single administration in rats preconditioned by two different mild stressors sequences

  2020cites this paper
• Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat.

  2019cites this paper
• Dose‐dependent effects of adenosine antagonists on tacrine‐induced tremulous jaw movements

  2018cites this paper
• Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis

  2018cites this paper
• Caffeine Potentiates the Ergogenic Effects of Creatine

  2017cites this paper
• Effects of Rifampin on the Pharmacokinetics of a Single Dose of Istradefylline in Healthy Subjects

  2017cites this paper
• Subthalamic and Cortical Local Field Potentials Associated with Pilocarpine-Induced Oral Tremor in the Rat

  2016cites this paper
• Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism.

  2016cites this paper
• Pramipexole reduces parkinsonian tremor induced by pilocarpine infusion in the rat striatum.

  2015cites this paper
• Characteristics of Tremorogenesis and Tremorolytic Agents in a Pharmacological Rodent Model of Parkinsonism: Evidence from Behavioral, Neurochemical, and Electrophysiological Studies

  2015influential citation
• Dopamine/Adenosine Interactions Related to Tremor in Animal Models of Parkinsonism

  2015cites this paper
• Adenosine A 2A Receptor Antagonists as Drugs for Symptomatic Control of Parkinson’s Disease in Preclinical Studies

  2015cites this paper
• Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.

  2015cites this paper
• Chapter 38 – Physiological and Behavioral Assessment of Tremor in Rodents

  2015cites this paper
• Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism

  2015cites this paper
• The local application of a flavonoid, (-)-epicatechin, increases the spiking of globus pallidus neurons in a dose-dependent manner and diminishes the catalepsy induced by haloperidol.

  2015cites this paper
• Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model.

  2014cites this paper
• Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant

  2014cites this paper
• A Critical Evaluation of Behavioral Rodent Models of Motor Impairment Used for Screening of Antiparkinsonian Activity: The Case of Adenosine A2A Receptor Antagonists

  2014cites this paper
• Effects of cabergoline and rotigotine on tacrine-induced tremulous jaw movements in rats.

  2014cites this paper
• Beyond the basal ganglia: cFOS expression in the cerebellum in response to acute and chronic dopaminergic alterations.

  2014cites this paper
• The restructuring of muscarinic receptor subtype gene transcripts in c-fos knock-out mice.

  2013cites this paper
• The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.

  2013cites this paper
• ucleus accumbens neurotransmission and effort-related choice behavior in food otivation : Effects of drugs acting on dopamine , adenosine , and muscarinic cetylcholine receptors

  2013influential citation
• Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism

  2013influential citation
• Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice.

  2013cites this paper
• Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.

  2013influential citation
• Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.

  2013influential citation
• Istradefylline: First Global Approval

  2013cites this paper
• The Role of Adenosine in the Ventral Striatal Circuits Regulating Behavioral Activation and Effort-Related Decision Making: Importance for Normal and Pathological Aspects of Motivation

  2013cites this paper
• Changes in nucleus accumbens and neostriatal c‐Fos and DARPP‐32 immunoreactivity during different stages of food‐reinforced instrumental training

  2012cites this paper
• Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation.

  2012cites this paper
• Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice.

  2012cites this paper
• Award Number: W81XWH-11-1-0150 TITLE: Protection by Purines in Toxin Models of Parkinson's Disease PRINCIPAL INVESTIGATOR:

  2012cites this paper
• Tremulous Jaw Movements Induced by the VMAT2 Inhibitor Tetrabenazine

  2012influential citation
• Adenosine-Dopamine Interactions in the Open Field Arena: Studies Related to Locomotion and Anxiety

  2012cites this paper
• The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade.

  2012influential citation
• The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions.

  2012influential citation
• Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies.

  2011cites this paper
• Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.

  2011cites this paper
• Galantamine-induced tremulous jaw movements in rats: Reversal with adenosine A2A antagonists

  2011cites this paper
• Adenosine A2A-Receptor Antagonism and Pathophysiology of Parkinson’s Disease and Drug-Induced Movement Disorders

  2011cites this paper
• Pharmacological and Physiological Characterization of the Tremulous Jaw Movement Model of Parkinsonian Tremor: Potential Insights into the Pathophysiology of Tremor

  2011influential citation
• Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists

  2011cites this paper
• Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity.

  2010cites this paper
• Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes.

  2010cites this paper
• Role of dopamine–adenosine interactions in the brain circuitry regulating effort-related decision making: insights into pathological aspects of motivation

  2010cites this paper
• Preladenant, a novel adenosine A(2A) receptor antagonist for the potential treatment of parkinsonism and other disorders.

  2010cites this paper
• Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors.

  2010cites this paper
• Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism.

  2010cites this paper
• Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.

  2010influential citation